The National Cancer Institute (NCI) partnered with the Multiple Myeloma Research Foundation (MMRF) to incorporate MMRF’s genomic and clinical data into the NCI’s Genomic Data Commons (GDC), a core component of the Cancer Moonshot Initiative. MMRF is the first nonprofit organization to donate information to the GDC, which will include data for more than 30,000 patients with multiple myeloma (MM).
“Data sharing is essential to advancing cancer research, and I cannot overstate the value of the data that MMRF is providing,” said Doug Lowy, MD, acting director of the NCI.
MMRF’s CoMMpass (Relating Clinical Outcomes in MM to Personal Assessment of Genetic Profile) study, which has enrolled more than 1,150 patients and is the largest genomic and clinical study of MM, is of particular interest.
The genomic data from these analyses will be deposited in the GDC, with an anticipated sample size of nearly 1,000 cases by the spring of 2017.
Source: National Cancer Institute press release, September 28, 2016.